Magnetic resonance‐guided laser interstitial laser therapy (MRgLITT) and radiofrequency
ablation (RFA) represent two minimally invasive methods for the treatment of drug‐refractory …

Magnetic resonance‐guided laser interstitial thermal therapy (MRgLITT) has emerged as a
popular minimally invasive alternative to open resective surgery for drug‐resistant epilepsy …

Epilepsy surgery is the treatment of choice for patients with drug‐resistant seizures. A timely
evaluation for surgical candidacy can be life‐saving for patients who are identified as …

Why are people with focal epilepsy not continuously having seizures? Previous neuronal
signalling work has implicated gamma-aminobutyric acid balance as integral to seizure …

Targeted tissue ablation involving the anterior hippocampus is the standard of care for
patients with drug-resistant mesial temporal lobe epilepsy. However, a substantial …

Abstract Objective The RNS System is a direct brain‐responsive neurostimulation system
that is US Food and Drug Administration–approved for adults with medically intractable focal …

Objective Medial temporal lobe epilepsy (TLE) is the most common form of medication‐
resistant focal epilepsy in adults. Despite removal of medial temporal structures, more than …

Background Magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) is a
minimally invasive alternative to surgical resection for drug-resistant mesial temporal lobe …

BACKGROUND For patients with focal drug-resistant epilepsy (DRE), surgical resection of
the epileptogenic zone (EZ) may offer seizure freedom and benefits for quality of life. Yet …

Drug-resistant epilepsy (DRE) is defined as failure to achieve sustained seizure control with
adequate trials of two appropriate antiseizure medications (ASMs). DRE affects one-third of …